The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Aberrant DNA methylation is the most frequent molecular alteration in acute myeloid leukemia (AML). To identify methylation-silenced genes in AML, we performed microarray analyses in U937 cells exposed to the demethylating agent 5-aza-deoxy-cytidine. Overall, 274 transcripts were significantly induced. Interestingly, C/EBPdelta expression was significantly induced (more than 10-fold) by demethylation whereas expression of all other C/EBP family members remained unchanged. The C/EBPdelta promoter was strongly methylated in different leukemic cell lines and showed signs of a repressed chromatin state. Analyses of the promoter regions of the entire C/EBP family (alpha, beta, gamma, delta, epsilon, zeta) in bone marrow samples from AML patients (n = 80) and controls (n = 15) by mass spectrometry revealed that C/EBPdelta is the most commonly hypermethylated C/EBP gene in AML. Hypermethylation occurred in more than 35% of AML patients at primary diagnosis. A significant correlation (P = .016) was observed between hypermethylation of the C/EBPdelta promoter and low expression of C/EBPdelta in AML patients. C/EBPdelta promoter activity was strongly repressed by methylation in vitro, and transcriptional repression partially depended on MeCP2 activity. C/EBPdelta exhibited growth-inhibitory properties in primary progenitor cells as well as in Flt3-ITD-transformed cells. Taken together, C/EBPdelta is a novel tumor suppressor gene in AML that is silenced by promoter methylation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primary AML cells, including cells containing mutations or translocations of RUNX1, express very high levels of master drivers of hematopoietic lineage differentiation compared with non-malignant hematopoietic stem and progenitor cells (e.g. PU.1 and CEBPA) (Fig. 1) (20”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [27]
In the citing paper
“Yet, the AML cells are differentiation arrested by morphology and demonstrate epigenetic repression of key differentiation target genes of these same transcription factors (20”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [27]
In the citing paper
“High expression in leukemia cells of master differentiation driving transcription factors PU.1 and CEBPA yet epigenetic repression of differentiation target genes suggests that coregulator recruitment to the differentiation drivers could be altered (20”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [27]
In the citing paper
“Hypermethylation has also been reported for CpG in the promoter of CEBPD (CEBPδ), another late-differentiation gene target of CEBPA (53).”
From CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors (2012) · cites this paper as [53]
Citations
Cites
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data
Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J., Ansorge, W., Ball, C. A., Causton, H. C., et al. (2001) · Nature Genetics · doi:10.1038/ng1201-365 · Cited by 4,109
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
MethPrimer: designing primers for methylation PCRs
Li, L.-C., & Dahiya, R. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.11.1427 · Cited by 2,729
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,628
Das, P. M., & Singal, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.151 · Cited by 1,456
CCAAT/enhancer-binding proteins: structure, function and regulation
RAMJI, D. P., & FOKA, P. (2002) · Biochemical Journal · doi:10.1042/bj20020508 · Cited by 1,400
Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins
Hendrich, B., & Bird, A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6538 · Cited by 1,360
Ehrich, M., Nelson, M. R., Stanssens, P., Zabeau, M., Liloglou, T., Xinarianos, G., Cantor, C. R., Field, J. K., & van den Boom, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507816102 · Cited by 812
Self-citationThe PANTHER database of protein families, subfamilies, functions and pathways
Mi, H. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki078 · Cited by 803
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735
Cited by
Kantarjian, H. M., Thomas, X. G., Dmoszynska, A., Wierzbowska, A., Mazur, G., Mayer, J., Gau, J.-P., Chou, W.-C., Buckstein, R., Cermak, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.9429 · Cited by 1,169
MicroRNA dysregulation in gastric cancer: a new player enters the game
Wu, W. K. K., Lee, C. W., Cho, C. H., Fan, D., Wu, K., Yu, J., & Sung, J. J. Y. (2010) · Oncogene · doi:10.1038/onc.2010.352 · Cited by 277
“For instance, strong inflammatory response as a result of cytokine gene polymorphisms (”
BackgroundWouters, B. J., Jordà, M. A., Keeshan, K., Louwers, I., Erpelinck-Verschueren, C. A. J., Tielemans, D., Langerak, A. W., He, Y., Yashiro-Ohtani, Y., Zhang, P., et al. (2007) · Blood · doi:10.1182/blood-2007-02-073486 · Cited by 199
The Many Faces of C/EBPδ and their Relevance for Inflammation and Cancer
Balamurugan, K., & Sterneck, E. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.7224 · Cited by 165
“The overexpression of C/EBPδ in primary mouse hematopoietic progenitor cells or a cell line model of acute myelogenous leukemia (AML) leads to myeloid differentiation accompanied by upregulation of the G-CSF receptor and downregulation of c-myc expression [8, 101], as also seen in CML cell lines [91].”
BackgroundInfluentialAberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse
Kroeger, H., Jelinek, J., Estécio, M. R. H., He, R., Kondo, K., Chung, W., Zhang, L., Shen, L., Kantarjian, H. M., Bueso-Ramos, C. E., et al. (2008) · Blood · doi:10.1182/blood-2007-11-126227 · Cited by 159
Metadata
- Authors
- Agrawal, S., Hofmann, W.-K., Tidow, N., Ehrich, M., Boom, D. V. D., Koschmieder, S., Berdel, W. E., Serve, H., & Müller-Tidow, C.
- Affiliations
- University of Münster (DE)
- Department of Oncology and Hematology, University Hospital Benjamin Franklin, Berlin, Germany;
- Sequenom (United States) (US)
- Department of Medicine, Hematology and Oncology, University of Münster, Germany;
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2007-01-18
- Volume
- 109
- Issue
- 9
- Pages
- 3895-3905
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2050847600
- Cited by
- 119
- References
- 63
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 10 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 4 · 2015: 8 · 2014: 9 · 2013: 5 · 2012: 11
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- C/EBPδ, acute myeloid leukemia, promoter hypermethylation, DNA methylation, tumor suppressor gene silencing, MeCP2, C/EBP family, decitabine, transcriptional repression, FLT3-ITD, leukemia progenitor cells
- MeSH terms
- Decitabine, Antimetabolites, Antineoplastic, Azacitidine, Female, Humans, Male, Promoter Regions, Genetic, Leukemia, Myeloid, Acute, Gene Expression Regulation, Leukemic, DNA Methylation, U937 Cells, Oligonucleotide Array Sequence Analysis, Gene Silencing, Gene Expression Profiling, Tumor Suppressor Proteins, Chromatin Assembly and Disassembly, CCAAT-Enhancer-Binding Protein-delta, Methyl-CpG-Binding Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. https://app.cochat.ai/papers/10.1182/blood-2006-08-040147
- The paper
- Agrawal, S., Hofmann, W.-K., Tidow, N., Ehrich, M., Boom, D. V. D., Koschmieder, S., Berdel, W. E., Serve, H., & Müller-Tidow, C. (2007). The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. Blood. https://doi.org/10.1182/blood-2006-08-040147
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.